Paraneoplasic neurologic syndromes;Síndromes paraneoplásicos neurológicos

Medicina Clinica

Volumn 125, Issue 14, 2005, Pages 543-547

  Erro Aguirre, María Elena ^a,b   Maisterra Santos, Olga ^a   Gallego Culieré, Jaime ^a  

^a Universidad Pública de Navarra   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; AZATHIOPRINE; BACLOFEN; CARBAMAZEPINE; CHLORAMBUCIL; CHOLINESTERASE INHIBITOR; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DIAZEPAM; DIPHENHYDRAMINE; FLUDARABINE; GLUCOCORTICOID; IMMUNOGLOBULIN; TACROLIMUS;

ARTICLE; DISEASE CLASSIFICATION; EATON LAMBERT SYNDROME; HUMAN; MOTOR NEURON DISEASE; MYOCLONUS; MYOKYMIA; OPSOCLONUS; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PLASMAPHERESIS; POLYNEUROPATHY; SENSORIMOTOR NEUROPATHY; SPINAL CORD DISEASE; TREATMENT OUTCOME;

EID: 28544442796     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080457     Document Type: Article

References (50)

1. Posner JB. Paraneoplastic syndromes. Rev Neurol (Paris). 2002;158: 899-906.
2. Bataller L, Dalmau J. Anticuerpos antineuronales y síndromes neurológicos paraneoplásicos. Neurología. 2002;17:85-96.
3. Bechich S, Graus F. El diagnóstico actual de los síndromes paraneoplásicos. Continua Neurológica. 2000;3:16-26.
4. Dalmau J, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 1997;24:318-28.
5. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, for the paraneoplastic neurological syndrome euronetwork. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135-40.
6. Bataller L, Dalmau J. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment. Semin Neurol. 2003;23:215-24.
7. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;16:1543-54.
8. Darnell RB. Paraneoplastic neurologic disorders. Windows into neuronal function and tumor immunity. Arch Neurol. 2004;61:30-2.
9. Dalmau J. Síndromes neurológicos paraneoplásicos: desde el diagnóstico de exclusión a la utilización de marcadores inmunológicos y moleculares. Neurología. 2000;15:114-26.
10. Scaravilli F, An SF, Groves M, Thom M. The neuropathology of paraneoplastic syndromes. Brain Pathology. 1999;9:251-60.
11. Ferrer I. Patología de los síndromes paraneoplásicos del sistema nervioso central, periférico y músculo. Rev Neurol. 2000;31:1228-36.
12. Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol. 1999;56:405-8.
13. Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu-associated paraneoplastic encephalomyelitis. Neurology. 1998;51:1146-50.
14. Benyahia B, Liblau R, Merle-Béral H, Tourani JM, Dalmau J, Delattre J-Y. Cell-mediated auto-immunity in paraneoplastic neurologic syndromes with anti-Hu antibodies. Ann Neurol. 1999;45:162-7.
15. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Verdino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62:1177-82.
16. Graus F, Saiz A. Encefalitis límbica: un síndrome probablemente infradiagnosticado. Neurología. 2005;20:24-30.
17. Rojas I, Graus F, Keime-Guibert F, René R, Delattre JY, Ramón JM, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology. 2000;55:713-5.
18. Nakao YK, Motomura M, Fukudome T, Fukuda T, Shiraishi H, Yoshimura T, et al. Seronegative Lambert-Eaton myasthenic syndrome. Neurology. 2002;59:1773-5.
19. Linke R, Schroeder M, Helmberger T, Voltz R. Antibody-positive paraneoplastic neurologic syndromes. Neurology. 2004;63:282-6.
20. Tani T, Piao Y-S, Mori S, Ishihara N, Tanaka K, Wakabayashi K, et al. Chorea resulting from paraneoplastic striatal encephalitis. J Neurol Neurosurg Psychiatry. 2000;69:512-5.
21. Gultekin SH, Roseneild MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumor association in 50 patients. Brain. 2000;123:1481-94.
22. Graus F, Keime-Guibert F, René R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138-48.
23. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore). 1992;71:50-72.
24. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau JD. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol. 2001;50:339-48.
25. Keime-Guibert HF, Graus F, Bröet P, René R, Molinuevo JL, Ascaso C, et al. Clinical outcome of patients with anti-Hu-associated paraneoplastic encephalomyelitis after treatment of the tumor. Neurology. 1999;53: 1719-23.
26. Salmerón-Ato P, Medrano V, Morales-Ortiz A, Martínez- García F, Villaverde-González R, Bas A, et al. Degeneración cerebelosa paraneoplásica como inicio de un carcinoma indiferenciado de células pequeñas de páncreas. Rev Neurol. 2002;35:1112-5.
27. Rojas-Marcos I, Rousseaeu A, Keime-Guibert F, René R, Cartalat-Carel S, Delatre JY, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine (Baltimore). 2003; 82:216-23.
28. Graus F, Dalmau J, Vallderiola F, Ferrer I, René R, Marin C. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin disease. J Neuroimmunol. 1997;74:55-61.
29. Bataller L, Graus F, Saiz A, Vilchez J. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437-43.
30. Bataller L, Dalmau J. Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol. 2004;17:3-8.
31. Ling CPW, Pavesio C. Paraneoplastic syndromes associated with visual loss. Curr Opin Ophthalmology. 2003;14:426-32.
32. Rojas-Marcos I, Reñé R, Graus F. Síndromes paraneoplásicos en otoneurooftalmologia. Rev Neurol. 2000;31:1206-12.
33. Martín Escudero JC, Aparicio Blanco M, Borrego Pintado H, Del Villar Negro A, Carretero Sastre JL, Velasco Fernández C. Necrotizing myelopathy associated with neoplasia. A clinico-pathological study of 2 cases and a review of the literature. An Med Interna. 1991;8:497-500.
34. Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol. 1997;41:722-30.
35. Shaw PJ. Stiff-man syndrome and its variants. Lancet. 1999;353:86-7.
36. Grimaldi LM, Martino G, Braghi S, Quattrini A, Furlan R, Bosi E, et al. Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol. 1993;34:57-64.
37. Erro ME, Martínez T, Ayuso T, Iragui MI. Polineuropatía paraneoplásica con anticuerpos anti-anfifisina. Anales del Sistema Sanitario de Navarra. 2004;27:103-6.
38. Molinuelo JL, Graus F, René R, Guerrero A, Illa I. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol. 1998;44:976-80.
39. Antoine J-C, Mosnier J-F, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry. 1999;67:7-14.
40. Grisold W, Drlicek M. Paraneoplastic neuropathy. Curr Opin Neurology. 1999;12:617-25.
41. Oh SJ. Paraneoplastic vasculitis of the peripheral nervous system. Neurol Clin. 1997;15:849-63.
42. Newsom-Davis J, Buckley C, Clover L, Hart I, Maddison P, Tuzum E, et al. Autoimmune disorders of neuronal potassium channels. Ann N Y Acad Sci. 2003;998:202-10.
43. Lennon VA, Kryzer TJ, Greismann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995; 332:1467-74.
44. Voltz RD, Albrich WC, Nagele A, Schumm F, Wick M, Freiburg A, et al. Paraneoplastic myasthenia gravis, detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology. 1997;49:1454-7.
45. Illa I, Dalakas MC. Dermatomyositis, polymyositis and inclusion body myositis: current concepts. Rev Neurol (Paris). 1998;154:13-6.
46. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology. 1998;50: 764-7.
47. Tim RW, Massey JM, Sanders DB. Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment. Neurology. 2000;54;2176-8.
48. Counsell CE, McLeod M, Grant R. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology. 1994;44:1184-5.
49. Lladó A, Mannucci P, Carpentier AF, Paris S, Blanco Y, Saiz A, et al. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology. 2004;63:1947-9.
50. Keime-Guibert F, Graus F, Fleury A, René R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479-82.